Novavax Inc
Ferro, 3D Systems rise; Yum, Novavax fall

May. 11, 2021 04:19 PM EDT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday: Yum Brands Inc., down $2.77 to $119.15. ...

Novavax trials highlight Maryland’s COVID-fighting complex

By Rachel Logan, Julia Arbutus And Pierce Panagakos Of Capital News Service Mar. 23, 2021 02:02 PM EDT
When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers were...

Novavax, Vail Resorts rise; Ulta Beauty, Zumiez fall

Mar. 12, 2021 04:24 PM EST
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday: Novavax Inc., up $15.14 to $202.77. ...

People wait after receiving the Pfizer/BioNTech vaccine against the COVID-19 in a vaccination center in the Lyon sports arena, central France, Thursday, Fev. 18, 2021. French Health Minister Olivier Veran promised stepped-up testing and vaccinations, but the government has resisted calls from some local doctors and leaders for a new lockdown. (AP Photo/Laurent Cipriani)
The Latest: Nevada has 1st confirmed case of SAfrica variant

By The Associated Press Feb. 18, 2021 05:57 AM EST

FILE - In this Nov. 12, 2020, file photo, people walk in a market to shop ahead of the Diwalli festival in New Delhi, India. Scientists say it's still too early to predict the future of the coronavirus, but many doubt it will ever go away entirely. (AP Photo/Manish Swarup, File)
Virus may never go away but could change into mild annoyance

By Aniruddha Ghosal And Christina Larson Feb. 14, 2021 08:12 AM EST

Chevron, Johnson & Johnson fall; Novavax, Skyworks rise

Jan. 29, 2021 04:15 PM EST
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday: Novavax Inc., up $86.93 to $220.94. ...

FILE - In this Tuesday, May 26, 2020 photo released by Nucleus Network/ABC, clinical trial participants are monitored during Novavax COVID-19 vaccine testing in Melbourne, Australia. On Thursday, Jan. 28, 2021, Novavax said its vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not quite as well — against new mutated strains of the coronavirus circulating in that country and South Africa. (Patrick Rocca/Nucleus Network/ABC via AP)
Novavax COVID-19 vaccine works, but less so against variants

By Lauran Neergaard Jan. 28, 2021 04:34 PM EST

In this Tuesday, Dec. 29, 2020, photo provided by Johns Hopkins Center for American Indian Health, registered nurse Starla Garcia prepares a coronavirus vaccine in Chinle, Ariz., for someone who enrolled in the COVID-19 vaccine trials on the Navajo Nation and initially received a placebo. (Nina Mayer Ritchie/Johns Hopkins Center for American Indian Health via AP)
Fast rollout of virus vaccine trials reveals tribal distrust

By Felicia Fonseca Jan. 02, 2021 11:11 AM EST

Nebraska participating in test of new potential vaccine

Dec. 30, 2020 10:18 AM EST
OMAHA, Neb. (AP) — The University of Nebraska Medical Center and Nebraska Medicine are participating in national testing of a potential new coronavirus vaccine...

Administrative worker Leslie Castillo, right, hands a COVID-19 testing kit to a man at a testing site in Los Angeles, Sunday, Dec. 27, 2020. Hospitals in central and Southern California are quickly running out of intensive care unit beds for coronavirus patients and state officials are poised to extend the strictest stay-at-home orders there as conditions worsen before the post-holiday surge hits. (AP Photo/Jae C. Hong)
VIRUS TODAY: State legislatures to convene amid pandemic

By The Associated Press Dec. 29, 2020 01:29 PM EST

Pharmacist Nadine M. Mackey, right, and registered nurse Gloria Campbell, center, react after Campbell received a COVID-19 vaccination at PowerBack Rehabilitation, in Phoenixville, Pa., Monday, Dec. 28, 2020. (Jose F. Moreno/The Philadelphia Inquirer via AP)
More COVID-19 vaccines in the pipeline as US effort ramps up

By Lauran Neergaard Dec. 28, 2020 04:02 PM EST

Military personnel rest after being vaccinated for COVID-19 at The Heroic Military College in Mexico City, Sunday, Dec. 27, 2020. The second batch of vaccines produced by Pfizer and its German partner, BioNTech, arrived in Mexico on Saturday. (AP Photo/Ginnette Riquelme)
Mexico might allow private firms to buy, distribute vaccines

Dec. 28, 2020 02:25 PM EST

Administrative worker Sander Edmondson, left, hands a COVID-19 testing kit to a woman at a testing site in Los Angeles, Sunday, Dec. 27, 2020. Hospitals in central and Southern California are quickly running out of intensive care unit beds for coronavirus patients and state officials are poised to extend the strictest stay-at-home orders there as conditions worsen before the post-holiday surge hits. (AP Photo/Jae C. Hong)
VIRUS TODAY: Huge study on another COVID vaccine is underway

By The Associated Press Dec. 28, 2020 12:31 PM EST

A resident wearing a mask to protect from the coronavirus waits at a bus stop near rainbow decorations on the streets of Beijing on Sunday, Dec. 27, 2020. Beijing has urged residents not to leave the city during the Lunar New Year holiday in February, implementing new restrictions and mass testings after several coronavirus infections last week. (AP Photo/Ng Han Guan)
The Latest: S Korea reports biggest daily death toll so far

By The Associated Press Dec. 28, 2020 03:30 AM EST

Nikola, JetBlue fall; Moderna, Novavax rise

Nov. 30, 2020 04:18 PM EST
NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday: Moderna Inc., up $25.71 to $152.74. The...

FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (AP Photo/Hans Pennink, File)
Moderna asking US, European regulators to OK its virus shots

By Lauran Neergaard Nov. 30, 2020 07:02 AM EST

This photo shows the outside of a Charleston, S.C., condominium belonging to Eugene Zurlo on Monday, Oct. 19, 2020. The Trump administration recently gave the longtime Republican political donor seed money to test a possible COVID-19-fighting blood plasma technology, noting Zurlo's "manufacturing facilities" in Charleston. An AP investigation found no manufacturing facilities. The company operates out of Zurlo's condo. He and his partners may now be in line for as much as $65 million in taxpayer money. (AP Photo/Meg Kinnard)
Trump admin. funds plasma company based in owner's condo

By Richard Lardner And Jason Dearen Nov. 01, 2020 08:24 AM EST

This photo shows the outside of a Charleston, S.C., condominium belonging to Eugene Zurlo on Monday, Oct. 19, 2020. The Trump administration recently gave the longtime Republican political donor seed money to test a possible COVID-19-fighting blood plasma technology, noting Zurlo's "manufacturing facilities" in Charleston. An AP investigation found no manufacturing facilities. The company operates out of Zurlo's condo. He and his partners may now be in line for as much as $65 million in taxpayer money. (AP Photo/Meg Kinnard)
Trump admin funds plasma company based in owner's condo

By Richard Lardner And Jason Dearen Nov. 01, 2020 08:13 AM EST

Novavax, Endo rise; Cavco, Occidental Petroleum fall

Sep. 25, 2020 04:17 PM EDT
NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday: Novavax Inc., up $11.12 to $113.56. The...

Novavax, Sunrun rise; Shake Shack, United Airlines fall

Jul. 07, 2020 04:19 PM EDT
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Tuesday: Livongo Health Inc., up $16.13 to $93.76. ...